Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

The coefficient path map and cross-validation curve from LASSO regression reveal the clinical background information associated with BECT, along with the most relevant feature columns selected by LASSO regression: Age, Central, Temporal, Facial Seizures, Limb Seizures, Background, Spike-and-Slow-Wave Complexes, Spikes, Lactate Dehydrogenase, Eosinophil Percentage, Neutrophil Percentage, Basophil Count, and 25-Hydroxyvitamin D (total 25-hydroxyvitamin D).

Source: 3.2. Feature selection. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

SeLECTS-assisted identification based on structured EEG reports: Development and external validation of a multicenter machine learning model

Study design awaiting verification · Medicine · 2026

Original publication title

SeLECTS-assisted identification based on structured EEG reports: Development and external validation of a multicenter machine learning model

Lijun Li; Lingxiang Ao; Lei Li; Li Wang; Xiaomei Liu; Kai Liu

Copyright © 2026 the Author(s). Published by Wolters Kluwer Health, LLC.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Benign epilepsy with centrotemporal spikes (SeLECTS) is a common pediatric epilepsy characterized by high-amplitude central: temporal spikes on electroencephalogram (EEG). Early identification remains challenging owing to inter-reader variability and inter-center protocol differences. Existing models often rely on single-center raw EEG, limiting generalizability and clinical deployment. An explainable, cross-institutional tool built on structured EEG reports plus routine laboratory tests could improve screening and workflow. This study aimed to develop a machine learning model for SeLECTS assistance and validate its performance on an external dataset, comparing multiple algorithms and evaluating discrimination, calibration, and net clinical benefit, with interpretable outputs for quality control and patient stratification.

We performed a multicenter retrospective study (internal n = 1067; external n = 94). Among 242 candidate variables, those with >20% missingness were removed; remaining missing data were handled by multiple imputation. Least Absolute Shrinkage and Selection Operator selected 13 key features, including age; central/temporal discharge localization; spikes or spike: wave complexes; background rhythm; facial/limb clonus; and laboratory indices (e.g., lactate dehydrogenase, white blood cell differential, 25-hydroxyvitamin D). Ten common classifiers were trained and tested. Area Under the Receiver Operating Characteristic Curve (AUROC) was the primary metric; accuracy, sensitivity, specificity, and F1 score were secondary.

Calibration and decision curve analyses assessed probability agreement and clinical net benefit. SHapley Additive exPlanations provided global and patient-level interpretability. eXtreme Gradient Boosting performed best. Internal validation yielded AUROC 0.97, accuracy 0.91, sensitivity 0.83, and specificity 0.94. External validation showed AUROC 0.96, accuracy 0.88, sensitivity 0.74, and specificity 0.94. Compared with internal performance, external results declined only slightly (AUROC −0.01; accuracy −0.03; sensitivity −0.09; specificity unchanged). Calibration indicated close agreement between predicted and observed risks. Decision curve analysis showed consistent positive net benefit across low-to-moderate thresholds.

SHapley Additive exPlanations highlighted temporal discharges, age, central discharges, and Lactate Dehydrogenase as leading contributors, consistent with known SeLECTS characteristics. Using 13 multicenter, routinely available features, the eXtreme Gradient Boosting model demonstrated high discrimination, good calibration, and meaningful net benefit in internal and external cohorts. Designed as a second-view aid after EEG reporting, the interpretable, lightweight model supports risk alerts and tiered review and is suitable for scalable deployment across centers.

Authors’ abstract

Benign epilepsy with centrotemporal spikes (SeLECTS) is a common pediatric epilepsy characterized by high-amplitude central: temporal spikes on electroencephalogram (EEG). Early identification remains challenging owing to inter-reader variability and inter-center protocol differences. Existing models often rely on single-center raw EEG, limiting generalizability and clinical deployment. An explainable, cross-institutional tool built on structured EEG reports plus routine laboratory tests could improve screening and workflow. This study aimed to develop a machine learning model for SeLECTS assistance and validate its performance on an external dataset, comparing multiple algorithms and evaluating discrimination, calibration, and net clinical benefit, with interpretable outputs for quality control and patient stratification.

We performed a multicenter retrospective study (internal n = 1067; external n = 94). Among 242 candidate variables, those with >20% missingness were removed; remaining missing data were handled by multiple imputation. Least Absolute Shrinkage and Selection Operator selected 13 key features, including age; central/temporal discharge localization; spikes or spike: wave complexes; background rhythm; facial/limb clonus; and laboratory indices (e.g., lactate dehydrogenase, white blood cell differential, 25-hydroxyvitamin D). Ten common classifiers were trained and tested. Area Under the Receiver Operating Characteristic Curve (AUROC) was the primary metric; accuracy, sensitivity, specificity, and F1 score were secondary.

Calibration and decision curve analyses assessed probability agreement and clinical net benefit. SHapley Additive exPlanations provided global and patient-level interpretability. eXtreme Gradient Boosting performed best. Internal validation yielded AUROC 0.97, accuracy 0.91, sensitivity 0.83, and specificity 0.94. External validation showed AUROC 0.96, accuracy 0.88, sensitivity 0.74, and specificity 0.94. Compared with internal performance, external results declined only slightly (AUROC −0.01; accuracy −0.03; sensitivity −0.09; specificity unchanged). Calibration indicated close agreement between predicted and observed risks. Decision curve analysis showed consistent positive net benefit across low-to-moderate thresholds.

SHapley Additive exPlanations highlighted temporal discharges, age, central discharges, and Lactate Dehydrogenase as leading contributors, consistent with known SeLECTS characteristics. Using 13 multicenter, routinely available features, the eXtreme Gradient Boosting model demonstrated high discrimination, good calibration, and meaningful net benefit in internal and external cohorts. Designed as a second-view aid after EEG reporting, the interpretable, lightweight model supports risk alerts and tiered review and is suitable for scalable deployment across centers.

Publication and source details

Original title: SeLECTS-assisted identification based on structured EEG reports: Development and external validation of a multicenter machine learning model

Lijun Li; Lingxiang Ao; Lei Li; Li Wang; Xiaomei Liu; Kai Liu

Medicine · 2026

* Correspondence: Kai Liu, Comprehensive Pediatrics, Kunming Children’s Hospital & Children’s Hospital of Kunming Medical University, No. 28, Shulin Street, Xishan District, Kunming, China (e-mail: ynkmlk@foxmail.com).Copyright © 2026 the Author(s). Published by Wolters Kluwer Health, LLC.2026https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T22:12:11.266687+00:00

DOI: 10.1097/md.0000000000049480 · PMC13336960